JGC
SRTA

J. Goldman & Co’s Strata Critical Medical Inc SRTA Stock Holding History

J. Goldman & Co’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200,000
Closed -$1.01M – 578
2025
Q3 		$1.01M Buy
+200,000
New +$884K 0.03% 331

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

J. Goldman & Co's SRTA Position: Q1 2025 in Review

J. Goldman & Co sold out of Strata Critical Medical Inc (SRTA) in Q1 2025, closing a stake of 377,972 shares — an estimated $1.61M sold.

J. Goldman & Co first reported a position in SRTA in Q1 2023 and held it in 4 quarters. The position peaked at $1.61M in Q4 2024. 118 funds tracked by Wall St. Rank hold SRTA as of Q1 2025.

  • J. Goldman & Co reported no remaining Strata Critical Medical Inc position as of Q1 2025 after selling out during the quarter.
  • J. Goldman & Co sold 377,972 Strata Critical Medical Inc shares in Q1 2025, an estimated $1.61M.
  • J. Goldman & Co first reported a position in Strata Critical Medical Inc in Q1 2023 and held it in 4 quarters.
  • J. Goldman & Co's Strata Critical Medical Inc position peaked at $1.61M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2025.

Based on J. Goldman & Co's 13F filing for Q1 2025, filed 15 May 2025.